Natco Pharma gets EIR from USFDA for Hyderabad facility

In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.

from Moneycontrol Business News https://ift.tt/2niYPBw